What is Refine MD?
Refine MD operates as a physician-led medical spa headquartered in Menasha, Wisconsin, providing a comprehensive suite of non-surgical aesthetic interventions. By catering to the Appleton, Neenah, and Menasha markets, the company has established a robust regional presence. Their service portfolio is anchored in high-demand treatments, including neurotoxin injectables, dermal fillers, advanced laser therapies, and body contouring solutions. Unlike traditional day spas, Refine MD leverages a clinical framework to deliver medical-grade skincare and personalized aesthetic protocols, effectively bridging the gap between wellness and dermatology for a diverse clientele of men and women.
How much funding has Refine MD raised?
Refine MD has raised a total of $92K across 1 funding round:
Debt
$92K
Debt (2021): $92K with participation from PPP
Key Investors in Refine MD
PPP
Public-Private Partnership
Undisclosed Investors
Undisclosed Investors
What's next for Refine MD?
The infusion of $92K serves as a catalyst for the next phase of the company's growth strategy. As Refine MD transitions through its current Series B/C stage, the focus is expected to shift toward scaling its service delivery model and potentially expanding its physical footprint within the Wisconsin corridor. By prioritizing the integration of cutting-edge aesthetic technologies and maintaining a high standard of physician-led care, the organization is poised to capture a larger share of the burgeoning non-invasive cosmetic market. Future strategic initiatives will likely involve optimizing operational efficiencies and deepening its market penetration through targeted patient acquisition programs.
See full Refine MD company page
